Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 075987
Company: CHARTWELL

Products on ANDA 075987

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
OXAPROZIN	OXAPROZIN	600MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 075987

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/02/2004	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/18/2020	SUPPL-9	Labeling-Package Insert, Labeling-Patient Package Insert		Label is not available on this site.
11/18/2020	SUPPL-8	Labeling-Package Insert		Label is not available on this site.
10/01/2012	SUPPL-6	Labeling		Label is not available on this site.
05/19/2006	SUPPL-3	Labeling		Label is not available on this site.

Therapeutic Equivalents for ANDA 075987

OXAPROZIN

TABLET;ORAL; 600MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DAYPRO	OXAPROZIN	600MG	TABLET;ORAL	Prescription	Yes	AB	018841	PFIZER
OXAPROZIN	OXAPROZIN	600MG	TABLET;ORAL	Prescription	No	AB	208633	AMNEAL PHARMS CO
OXAPROZIN	OXAPROZIN	600MG	TABLET;ORAL	Prescription	No	AB	075987	CHARTWELL
OXAPROZIN	OXAPROZIN	600MG	TABLET;ORAL	Prescription	No	AB	075855	DR REDDYS LABS LTD
OXAPROZIN	OXAPROZIN	600MG	TABLET;ORAL	Prescription	No	AB	075845	SANDOZ